A phase IA, two-arm, multicenter, dose-escalation study of oral AEE788 administered either daily or twice weekly in adult patients with advanced colorectal cancer with liver metastases

Trial Profile

A phase IA, two-arm, multicenter, dose-escalation study of oral AEE788 administered either daily or twice weekly in adult patients with advanced colorectal cancer with liver metastases

Recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Dec 2005

At a glance

  • Drugs AEE 788 (Primary)
  • Indications Cancer metastases; Colorectal cancer
  • Focus Adverse reactions
  • Sponsors Novartis
  • Most Recent Events

    • 13 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top